Amgen's Dividend Announcement for Fourth Quarter 2024
Amgen (NASDAQ: AMGN), a leader in the biotechnology industry, has made a significant announcement regarding its dividend for the fourth quarter of the year. The Board of Directors has declared a dividend of $2.25 per share. This move is reflective of the company's strong financial position and commitment to delivering value to its shareholders.
Financial Highlights
This quarterly dividend is set to be paid on a designated date to all stockholders recorded by a specified cutoff. The announcement indicates a forward-thinking strategy that resonates with Amgen's dedication to maintaining shareholder trust and engagement.
About Amgen
For over 40 years, Amgen has positioned itself at the forefront of biotechnology. The company focuses on discovering, developing, manufacturing, and delivering innovative medicines aiming to assist millions of patients battling tough diseases. Amgen's commitment to scientific progress and dedication to sustaining global health have established it as a pioneer in the industry.
Recognitions and Achievements
In recent years, Amgen has received numerous accolades, underscoring its innovative capabilities. Among these, the company was named one of the "World's Most Innovative Companies" by Fast Company and recognized as one of "America's Best Large Employers" by Forbes. The company's inclusion in the Dow Jones Industrial Average and the Nasdaq-100 Index emphasizes its stature as a top-tier biotechnology firm.
Continued Commitment to Innovation
Amgen continues to expand its broad pipeline of products that address a myriad of health challenges, including cancer, heart disease, osteoporosis, and rare diseases. The integration of technology with human genetic data allows Amgen to stay ahead in the realm of medical advancements, pushing barriers beyond what was previously understood.
Contact Information
For further inquiries about the dividend and company initiatives, Amgen can be reached through its contact representatives. Elissa Snook is available for media-related questions, while Justin Claeys handles investor relations. Both can provide additional insights regarding the company's operations and strategic direction.
Frequently Asked Questions
What is the dividend amount declared by Amgen for Q4 2024?
Amgen has declared a dividend of $2.25 per share for the fourth quarter of 2024.
When will the dividend be paid?
The dividend will be paid on a specified date for all shareholders of record by a cutoff date.
What makes Amgen a leader in the biotechnology field?
With over 40 years of experience, Amgen has developed innovative medicines and maintains a robust pipeline targeting various diseases.
How has Amgen been recognized in recent years?
Amgen has received various awards, including recognition as one of the "World's Most Innovative Companies" and one of "America's Best Large Employers."
Who can I contact for more information about Amgen's initiatives?
Elissa Snook is the media contact, while Justin Claeys manages investor inquiries. Both can provide detailed information about the company's latest ventures.
